$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
Want to Get Rich? 3 Game-Changing Growth Stocks to Buy Right Now
05:58am, Monday, 28'th Aug 2023
Growth stocks continue to drive both the stock market and investors' portfolios. Game-changing growth stocks to buy that have multi-year catalysts to drive their earnings and share price steadily high
Is It Too Late to Buy Eli Lilly Stock?
07:20am, Sunday, 27'th Aug 2023
Eli Lilly continued to grow like a weed in the second quarter. The company's dividend payout ratio is somewhat low.
Accused Of Excluding Older Applicants, Eli Lilly Settles Again
06:27am, Sunday, 27'th Aug 2023
Eli Lilly settled another age discrimination lawsuit for an undisclosed amount, just two months after reaching a $2.4 million settlement with the EEOC.
This New Development Is Helping to Send Eli Lilly and Novo Nordisk Stocks Soaring
10:23am, Thursday, 24'th Aug 2023
A new study by Novo Nordisk points to GLP-1 drugs reducing cardiac risks. It's a relevant finding for Eli Lilly, too, which is already moving forward in clinical trials.
Got $5,000? Invest in These 2 Unstoppable Growth Stocks.
09:53am, Wednesday, 23'rd Aug 2023
Eli Lilly could see a couple of key drug approvals from the FDA in the near future. Strong travel demand and an improved platform position Airbnb for continued growth.
Sell Eli Lilly And Buy This Coiled-Spring Dividend Aristocrat Instead
07:00am, Wednesday, 23'rd Aug 2023
The Nasdaq's 15-year period of zero returns highlights the importance of valuation in the long term. Eli Lilly is in an epic bubble, pricing in all growth through 2036 and trading at almost 60X forwar
Could This 1 Problem Put a Dent in Novo Nordisk and Eli Lilly Stock?
10:15am, Tuesday, 22'nd Aug 2023
Novo Nordisk and Eli Lilly want to use their medicines to treat NASH, a liver disease. Their chances of success are more uncertain than shareholders might wish to see.
Eli Lilly reports positive results from study of thyroid cancer treatment
08:32am, Tuesday, 22'nd Aug 2023
Eli Lilly & Co. LLY, +0.66% on Tuesday reported positive results from a study evaluating its targeted therapy Retevmo versus the current standard initial treatments for patients with advanced or metas
These 3 Large-Cap Pharma Stocks Have Been Red-Hot
09:02pm, Monday, 21'st Aug 2023
Large-cap pharmaceuticals have enjoyed buying pressure over the last month, delivering outsized gains to investors. And these three stocks have helped lead the charge.
5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain Pace
11:16am, Monday, 21'st Aug 2023
Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Novartis (NVS) and AstraZeneca (AZN) are wo
3 Fantastic Stocks to Buy in a New Bull Market
06:54am, Sunday, 20'th Aug 2023
Eli Lilly has explosive growth potential. Novo Nordisk is worth its premium price tag.
Eli Lilly (LLY) Stock Up Almost 50% Year to Date: Here's Why
01:17pm, Thursday, 17'th Aug 2023
Sales of Lilly's (LLY) new drug, Mounjaro are already benefiting from strong demand trends. Lilly expects regulatory decisions for some key pipeline candidates this year, which are key to growth.
3 of Eli Lilly's Top Drugs Grew by Over 40% in Q2. Trulicity Wasn't One of Them.
09:53am, Thursday, 17'th Aug 2023
Eli Lilly's sales growth last quarter was driven in large part by three drugs. Trulicity remains the company's top seller, but it might not stay that way for long.
3 Reasons to Buy Eli Lilly Stock
10:00am, Wednesday, 16'th Aug 2023
Eli Lilly's newest diabetes therapy is meeting its lofty expectations. Some of the company's other medicines are also performing well.
These 20 dividend stocks have been the best income growers in the S&P 500
10:10am, Tuesday, 15'th Aug 2023
In the comment section of a recent MarketWatch article listing stocks with high dividend yields that were expected to be well supported by the companies' cash flow, a reader suggested that it would ha
Sign In
Buy LLY